BSECompany Update6d ago · 13 Aug 2026, 06:45 pm
Audio Recording of investor(s)/analyst(s) meet Conference Call on Q1 FY 27 Financial Results
Marksans Pharma Ltd · 524404
✦ AI SummaryResults
Marksans Pharma Ltd has uploaded the audio recording of its investor/analyst conference call on Q1 FY 27 financial results on its website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
8a673cc6-f25a-476b-b016-5cfbf99dfa76.pdf
View document text
August 13, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400001. Bandra (East), Mumbai - 400051.
Scrip Code: 524404 Symbol: MARKSANS
Sub: Audio Recording of investor(s) / analyst(s) Conference Call on Q1FY27 Financial Results
Dear Sir/Madam,
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure
Requirements), Regulations, 2015, we hereby inform the stock exchanges that the Company has
uploaded the audio recording of investor(s) / analyst(s) conference call on Q1FY27 financial results held
today i.e. August 13, 2026 on the Company’s website at
https://www.marksanspharma.com/earnings-call-transcripts.html
You are requested to note the above in your records.
Thanking You.
Yours faithfully,
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri
(W), Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: companysecretary@marksanspharma.com
www.marksanspharma.com